4Grundy SM, Cleeman JI, Merz CN, et al. implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ Guidelines [ J ]. Circulation ,2004,110 ( 2 ) : 227 -239.
5Barth JD,Zonjee MM. Regression growth evaluation statin study(REGRESS): study design and baseline characteristics in 600 patients. The REGRESS Research Group[J]. Can J Cardiol,1992,8(9) :925-932.
6Schwartz GG,Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study:a randomized controlled trial [ J ]. JAMA, 2001,285 ( 3 ) : 1711 - 1718.
7Cannon CP, McCabe CH, Bendcy J, et al. Early statin therapy is associated with markedly lower mortality in patients with acute coronary syndromes:observations from OPUS-TIMI 16 [ J ]. J Am Coil Cardiot, 2001, 37 (2, suppl A) : 334A.
8Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins [ J ]. JAMA,1998,279(20) :1643.
9Walter DH,Schachinger V, Eisner M,et al. Effect of statin therapy on restenosis after coronary stent implantation [ J ]. Am J Cardiot,2000, 85 ( 8 ) :962.
10Krum H, Latini R, Maggioni AP, et al. Statins in symptomatic chronic systohc heart failure. A post-hoc analysis of 5 010 patients enrolled in Val-HEFT[ J ]. Eur Heart J,2007,119( 1 ) :45-53.
